ICW's Findings Lead to Apology and Promises from Raffi Ahmad
-
News
-
14 minutes ago
This article was translated by AI. Read the original article on Kompas.com. See Original
ASEAN Summit 49 in Manila, themed "Navigating Our Future, Together," presents a unique opportunity for Indonesia to assess and gauge its medical sovereignty regionally.
Why should we measure medical aspects in such a significant forum? Because our country is the largest contributor to medical consultations, treatments, and even medical tourism within ASEAN, primarily benefiting Singapore, Malaysia, and recently starting to include Thailand.
But what exactly are we measuring? How does this relate to sovereignty? The answer is that it certainly connects and will define Indonesia's future sovereignty.
However, measuring medical sovereignty must begin with a clear attitude towards patient choices, as countries need to respect those decisions and understand why domestic services have not become a preferred option.
We must also be realistic that some individuals will continue to seek treatment abroad, even as Indonesia’s services improve.
What needs to be measured is Indonesia's ability to convert the significant flow of patients into a bargaining position that advocates for safer services and more beneficial cooperation.
This is where medical issues become a diplomatic measure, as patients can select hospitals but cannot negotiate cross-border promotional oversight, data exchange, or complaint mechanisms between two countries.
There are interests that can only be advanced through intergovernmental relations, and a summit level like ASEAN should provide political direction for these initiatives.
The motivations from the patients' side are quite understandable as they seek expertise, certainty, comfort, or service experience perceived as superior, so Indonesia must examine its own systemic shortcomings that contribute to this outbound trend.
However, discussions become lopsided if the entire responsibility is placed on the home country while the destination country adeptly develops new methods to attract patients.
When neighboring governments support medical tourism growth as an industry, that support should come with a willingness to strengthen protections for those utilizing their services.
The enormity of this interest is evident in a report by the Malaysia Healthcare Travel Council, which noted 968,000 health tourism arrivals from Indonesia in 2025, generating revenues of RM 2.2 billion.
This count does not necessarily equate to unique individuals, and the numbers originate from destination countries' industry development agencies.
Such data substantiates that the relationship holds significant economic implications, hence it is reasonable for Indonesia to spark discussions that transcend mere promotion and medical transactions.
The destination country certainly has the right to showcase its service advantages, just as patients have the right to choose.
What needs to be demanded is a balanced commitment to attracting patients while ensuring their safety.
Marketing innovations can make services more easily accessible, but the government also needs to ensure that claims made by healthcare systems sold through packages from neighboring countries can be substantiated according to global medical standards, and patients understand what services they are entitled to.
The ease of obtaining a screening package should not lead individuals to assume that more tests always mean better health protection.
Thus, Indonesia must be bold in demanding that neighboring countries' attitudes should reflect in the oversight of the services they promote, ensuring that information about expertise, results, risks, and costs is communicated responsibly.
Countries benefiting from the growth of the market need to ensure that such growth does not compromise the thoroughness of care; this has become a rule-of-thumb in the global economy!
This responsibility should also extend to the period after patients return home, where destination hospitals need to provide adequate medical records, follow-up plans, and communication channels with doctors continuing care in Indonesia.
There are numerous cases where patients returning from heart catheterization surgeries in Malaysia or Singapore have required further medical attention and been treated, or even saved by Indonesian doctors due to new 'heart attack' incidents, without proper evaluation of whether this was a result of incomplete previous treatment.
If complications arise, patients must know how to obtain information and assistance, even though complications do not always indicate negligence; this situation still necessitates a response from the home hospital in the country providing medical services, which has undoubtedly profited.
The service relationship should not become difficult to access once patients have left the healthcare provider's country and returned to Indonesia.
The principle aligns with the WHO Patient Safety Rights Charter, which emphasizes patients' rights to comprehensible information, access to medical records, appropriate care, and fair resolution of complaints.
Indonesia can advocate for these rights to be translated into an ASEAN agreement applicable for cross-border services.
Based on this, patient protection should be integral to industrial development, not merely a promise within promotional material.
The summit, however, is not the place to detail every technical aspect of service.
Nonetheless, leaders can agree on direction, mandate health ministers and relevant agencies, and set implementation deadlines.
Indonesia could propose initial collaboration on networks of hospitals serving cross-border patients, requiring minimum obligations regarding pre-procedure information, treatment summaries, inter-facility communication, and complaint management.
However, diplomacy will lose its efficacy if we demand transparency in costs from neighbors while leaving patients struggling to understand bills; or seek continuity of care across borders while referral relationships between hospitals in Indonesia remain unaddressed.
Therefore, the diplomatic measure is quite clear: is Indonesia able to bring patient needs into a joint commitment with accountable parties, deadlines, and verifiable results?
And are neighboring countries willing to place safety and continuity of care at the heart of their medical tourism success?
If cooperation only results in increasingly attractive promotions and more accessible travel, the commercial benefits may grow, but the regional responsibilities may not evolve accordingly.
Indonesia's medical sovereignty can be tested by its ability to advocate for these interests without limiting citizens' choices and without evading criticism of its own services.
Patients who travel still deserve protection, while those who stay have the right to benefit from regional cooperation.
In a forum as significant as the ASEAN Summit, Indonesia should strive to ensure that health relations among nations flourish through clearly defined exchanges of capabilities and responsibilities.
Because, the proximity between nations will feel infinitely more meaningful when they continue to work for patients even after promotional activities are complete and the journey home has concluded.